Results 41 to 50 of about 79,327 (229)

Neutralization of the Plasmodium-encoded MIF ortholog confers protective immunity against malaria infection

open access: yesNature Communications, 2018
Plasmodium species produce an ortholog of the cytokine macrophage migration inhibitory factor, PMIF, which modulates the host inflammatory response to malaria.
Alvaro Baeza Garcia   +13 more
doaj   +1 more source

A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of Plasmodium falciparum [PDF]

open access: yes, 2016
Background: The malaria vaccine candidate RTS, S/AS01 (GSK Vaccines) induces high IgG concentration against the circumsporozoite protein (CSP) of Plasmodium falciparum.
Clement, Frédéric   +7 more
core   +4 more sources

Malaria vaccine development [PDF]

open access: yesClinical Microbiology Reviews, 1994
The malaria parasite life cycle presents several targets for attack, but these different parts of the life cycle are susceptible to different types of host immune response. For example, the sporozoite is most sensitive to immune antibody, while liver stage parasites can be eliminated by cytotoxic T lymphocytes. Attachment of merozoites to erythrocytes,
T R, Jones, S L, Hoffman
openaire   +2 more sources

Malaria infections do not compromise vaccine-induced immunity against tuberculosis in mice.

open access: yesPLoS ONE, 2011
BackgroundGiven the considerable geographic overlap in the endemic regions for malaria and tuberculosis, it is probable that co-infections with Mycobacterium tuberculosis and Plasmodium species are prevalent.
Marcela Parra   +9 more
doaj   +1 more source

Antibody and B cell responses to Plasmodium sporozoites [PDF]

open access: yes, 2014
Antibodies are capable of blocking infection of the liver by Plasmodium sporozoites. Accordingly the induction of anti-sporozoite antibodies is a major aim of various vaccine approaches to malaria.
Cockburn, Ian A.   +2 more
core   +2 more sources

The rise of companies from emerging markets in global health governance: opportunities and challenges [PDF]

open access: yes, 2014
The article analyses the involvement of pharmaceutical companies from emerging markets in global health governance. It finds that they play a central role as low-cost suppliers of medicines and vaccines and, increasingly, new technologies.
ANNE ROEMER-MAHLER   +23 more
core   +1 more source

The roles of resident, central and effector memory CD4 T cells in protective immunity following infection or vaccination [PDF]

open access: yes, 2018
Immunological memory provides rapid protection to pathogens previously encountered through infection or vaccination. CD4 T cells play a central role in all adaptive immune responses.
Gray, Joshua I.   +2 more
core   +1 more source

Lymphoid‐Tissue‐on‐Chip Recapitulates Human Antibody Responses In Vitro

open access: yesAdvanced Science, EarlyView.
The presented lymphoid‐tissue‐on‐chip system allows culture of primary human tonsil cells at organotypic high density under perfusion for up to 4 weeks, emulates immune response to soluble vaccines and vaccination via peripheral antigen‐presenting cells and represents a useful tool to assess cellular interactions during homeostasis, immune responses ...
Claudia Teufel   +15 more
wiley   +1 more source

Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates

open access: yesnpj Vaccines
Vaccines to the Plasmodium falciparum reticulocyte binding-like protein homologue 5 (PfRH5) target the blood-stage of the parasite life cycle. PfRH5 has the potential to trigger the production of strain-transcendent antibodies and has proven its efficacy
Laty G. Thiam   +18 more
doaj   +1 more source

Malaria vaccines and their potential role in the elimination of malaria

open access: yesMalaria Journal, 2008
Research on malaria vaccines is currently directed primarily towards the development of vaccines that prevent clinical malaria. Malaria elimination, now being considered seriously in some epidemiological situations, requires a different vaccine strategy,
Greenwood Brian M, Targett Geoffrey A
doaj   +1 more source

Home - About - Disclaimer - Privacy